A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity

Darren J. H. Tan,Chloe Wong,Cheng Han Ng,Chen Wei Poh,Sneha Rajiv Jain,Daniel Q. Huang,Mark D. Muthiah

DOI: https://doi.org/10.3390/jcm10020238

IF: 3.9

2021-01-11

Journal of Clinical Medicine

Abstract:Hepatocellular carcinoma (HCC) recurrence after liver transplant is associated with a poor prognosis and significantly increases morbidity and mortality among liver transplant patients. Therefore, this meta-analysis aims to evaluate the overall prevalence of HCC recurrence following liver transplant. Medline and Embase databases were searched, and a meta-analysis of proportions was conducted. Observational studies reporting the prevalence of recurrent hepatocellular carcinoma (HCC) after liver transplant were included, with the analysis being stratified by adherence to Milan criteria, ethnicity, socio-economic status, alpha fetoprotein (AFP) levels, living donor vs. deceased donor, and the underlying aetiology of the liver disease. A meta-regression on the date of the study completion was also performed. Of a total 40,495 patients, 3888 developed an HCC recurrence. The overall prevalence of recurrent HCC was 13% (CI: 0.12–0.15). Patients beyond the Milan criteria (MC) were more likely to recur than patients within MC. Asian populations had the greatest prevalence of HCC recurrence (19%; CI: 0.15–0.24) when compared to Western (12%; CI: 0.11–0.13) and Latin American populations (11%; CI: 0.09–0.14). The prevalence of recurrent HCC was the highest in patients infected with hepatitis B virus (HBV) (18%; CI: 0.11–0.27) compared to other aetiologies. A higher AFP also resulted in an increased recurrence. This highlights interesting differences based on ethnicity, income, and aetiology, and further studies are needed to determine the reasons for the disparity.

medicine, general & internal

What problem does this paper attempt to address?

The paper attempts to address the overall incidence of hepatocellular carcinoma (HCC) recurrence after liver transplantation and its relationship with etiology, alpha-fetoprotein (AFP), income, and race. Specifically, the study aims to evaluate the overall incidence of HCC recurrence after liver transplantation through systematic review and meta-analysis, and to explore the impact of the following factors on recurrence:

1. **Whether meeting Milan Criteria**: The study compared the differences in HCC recurrence rates between patients who met and did not meet the Milan Criteria.
2. **Race**: The study analyzed the differences in HCC recurrence rates among different racial groups (Asians, Westerners, Middle Easterners, and Latin Americans).
3. **Socioeconomic status**: The study explored the differences in HCC recurrence rates between patients from middle-income and high-income countries.
4. **Alpha-fetoprotein (AFP) levels**: The study analyzed the impact of preoperative AFP levels on HCC recurrence rates.
5. **Donor type**: The study compared the HCC recurrence rates after living donor and cadaveric donor transplants.
6. **Etiology of liver disease**: The study analyzed the impact of different etiologies (such as hepatitis B virus HBV, hepatitis C virus HCV, non-alcoholic steatohepatitis NASH, and alcoholic liver disease ALD) on HCC recurrence rates.

Through these analyses, the study hopes to identify key factors influencing HCC recurrence, thereby providing guidance for clinical practice and further research.